Clinical trials
Neoplasms, Glandular and Epithelial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 5 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sumitomo Pharma America, Inc. | 3 |
| Boston Scientific Corporation | 2 |
| National Cancer Institute (NCI) | 2 |
| Revolution Medicines, Inc. | 2 |
| Syndax Pharmaceuticals | 2 |
| Abbott | 1 |
| Advaxis, Inc. | 1 |
| Arsenal Biosciences, Inc. | 1 |
| Atara Biotherapeutics | 1 |
| Becton, Dickinson and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms, Glandular and Epithelial | 33 |
| Neoplasms | 26 |
| Neoplasms by Histologic Type | 21 |
| Carcinoma | 17 |
| Neoplasms by Site | 17 |
| Adenocarcinoma | 15 |
| Digestive System Neoplasms | 14 |
| Digestive System Diseases | 12 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Lung Neoplasms | 7 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.